As 0.9 per cent equity changed hands in the pre-opening deal, shares of Mankind Pharma will gain focus today. Earlier in March this year, investor Beige reportedly sold up to a 2.9 per cent stake in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results